Primary Site >> Liver Cancer
Gene >> ACSL4
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Fatty acid-CoA ligase 4 is overexpressed in human hepatocellular carcinoma. PMID: 12824887 Ref: Glypican-3 is overexpressed in human hepatocellular carcinoma. PMID: 12824919 |
Ref: PCR-array gene expression profiling of hepatocellular carcinoma. PMID: 15149162 |
Ref: Involvement of fatty acid-CoA ligase 4 in hepatocellular carcinoma growth: roles of cyclic AMP and p38 mitogen-activated protein kinase. PMID: 15849811 |
Ref: Regulation of cell growth by fatty acid-CoA ligase 4 in human hepatocellular carcinoma cells. PMID: 17934335 |
Ref: The effect of fatty acid-CoA ligase 4 on the growth of hepatic cancer cells. PMID: 18059177 |
Ref: Functional interaction between acyl-CoA synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells. PMID: 21085606 |
Ref: A novel TIP30 protein complex regulates EGF receptor signaling and endocytic degradation. PMID: 21252234 |
Ref: The functional interaction between Acyl-CoA synthetase 4, 5-lipooxygenase and cyclooxygenase-2 controls tumor growth: a novel therapeutic target. PMID: 22808264 |
Ref: Microarray analysis provides new insights into the function of apolipoprotein O in HepG2 cell line. PMID: 24341743 |
Ref: Involvement of cholesterol in hepatitis B virus X protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating miR-205-targeted ACSL4. PMID: 24576478 |
Ref: Simultaneous silencing of ACSL4 and induction of GADD45B in hepatocellular carcinoma cells amplifies the synergistic therapeutic effect of aspirin and sorafenib. PMID: 28900541 |
Ref: Signature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection. PMID: 30138348 |